Due Diligence

Technology, market, customers, competitors, business model, regulatory strategy, reimbursement – in the life sciences, you need to go a level deeper to understand the attractiveness and positioning of your target investment. DeciBio can get you there.

Our Experts

David Cavanaugh

David Cavanaugh

Carl Schoellhammer

Carl Schoellhammer

Stephane Budel

Schedule a Call

Related Client Results

All Client Results

VOC research, competitive assessment for a novel multi-omic technology

A ~$100M research tools and diagnostic company wanted to understand key applications and revenue potential of their novel technology to inform a go / no-go development decision

Pricing Strategy

Voice-of-Customer Research

Competitive Analysis

Market Landscaping and Sizing

Novel Technology Commercialization

Financial Services

PE-Backed Life Sciences Tools Platform Development

A leading private equity firm and management team sought out DeciBio as a strategic partner to advise on the life sciences market and perform due-diligences in support of the development of a novel life sciences tools platform

Voice-of-Customer Research

Customer Segmentation

Pricing Strategy

Due Diligence

Competitive Analysis

Clinical Diagnostics

Genetic Testing Company Assessment

A group asked DeciBio to identify and evaluate clinical genetic testing labs for potential acquisition

Target Identification

Clinical Diagnostics

RNA-based Oncology Biomarker Market Landscape

A cancer diagnostics company wanted to understand the current and future landscape for RNA-based oncology biomarkers, focusing on gene expression profiling (GEP) and rearrangements across medical settings

Voice-of-Customer Research

Competitive Analysis

Biomarker and Diagnostics Strategy

Product Specification Mapping

Pharma & Biotech

Biopharma Genomic Testing Market Research

A diagnostic company wanted to assess the current and expected future landscapes for biopharma oncology genomics research and Dx / CDx

Voice-of-Customer Research

Synthetic Oligonucleotides Market Sizing

A leader in synthetic oligonucleotide manufacturing wanted to assess the total market size and opportunity

No items found.

Precision Medicine is evolving at a rapid pace

Discover how we can help